loading page

Evaluation of the Effects of Apatinib on the Pharmacokinetics of Tramadol and O-desmethyltramadol
  • +4
  • Susu Bao,
  • Peng-fei Tang,
  • Nan-yong Gao,
  • Xiang-ran Lu,
  • Hong-lei Ge,
  • Guoxin Hu,
  • Zhong-xiang Xiao
Peng-fei Tang
Author Profile
Nan-yong Gao
Author Profile
Xiang-ran Lu
Author Profile
Hong-lei Ge
Author Profile
Guoxin Hu
Wenzhou Medical University
Author Profile
Zhong-xiang Xiao
Affiliated Yueqing Hospital, Wenzhou Medical University

Corresponding Author:[email protected]

Author Profile


Since the combination of anticancer drugs and opioids is very common, apatinib and tramadol are likely to be used in combination clinically. Based on this, it is particularly important to explore the effect of apatinib on the metabolism of tramadol. This study evaluated the effects of apatinib on the pharmacokinetics of tramadol and its main metabolite o-desmethyltramadol in SD rats and the inhibitory effects of apatinib on tramadol in rat liver microsomes (RLMs), human liver microsomes (HLMs) and recombinant human CYP2D6.1. The samples were determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). The in vivo results showed that compared with the control group, apatinib increased the AUC(0-t), AUC(0-∞) and Cmax values of tramadol and O-desmethyltramadol, and decreased the values of VZ/F and CLz/F. In addition, the MRT(0-t), MRT(0-∞) values of O-desmethyltramadol were increased. In vitro, apatinib inhibited the metabolism of tramadol by a mixed way with IC50 of 1.927µM in RLMs, 2.039µM in HLMs and 15.32µM in CYP2D6.1.